Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...

Princeton: BioNTech SE and Bristol Myers Squibb have announced that the companies have entered into an agreement for the ...

BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure ...

A new COVID variant, NB.1.8.1, was detected in Washington. These are the symptoms to watch for and recommended vaccinations.

Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

The chief executive of a speciality chemicals giant which is one of only two Yorkshire-headquartered FTSE 100 constituents ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

With U.S. stocks booming, North American wealthy led the way globally. And the top 1% of wealthy globally—the so-called ...

The fraught discussions playing out between President Donald Trump and one of the world’s most powerful figures could shape ...